Cargando…
Glucocorticoids/siltuximab/tocilizumab: Hepatitis-B reactivation following off-label use: 2 case reports
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7820099/ http://dx.doi.org/10.1007/s40278-021-89988-2 |
Ejemplares similares
-
Tocilizumab: Hepatitis-B viral reactivation with acute hepatitis following an off-label treatment: case report
Publicado: (2021) -
Corticosteroids/tocilizumab: Reactivation of Mycobacterium tuberculosis following off-label therapy: case report
Publicado: (2020) -
Tocilizumab: Anaphylaxis following off-label use: case report
Publicado: (2021) -
Tocilizumab: Neutropenia following off-label use: case report
Publicado: (2021) -
Tocilizumab: Septic shock following off-label use: case report
Publicado: (2020)